Mem Inst Oswaldo Cruz, Rio de Janeiro, 112(12) December 2017
Original Article

Dengue serotype-specific immune response in Aedes aegypti and Aedes albopictus

Chelsea T Smartt+, Dongyoung Shin, Barry W Alto

University of Florida, Department of Entomology and Nematology, Florida Medical Entomology Laboratory, Vero Beach, FL, USA

Page: 829-837 DOI: 10.1590/0074-02760170182
696 views 971 downloads

BACKGROUND Dengue viruses (DENV) are considered one of the most important emerging pathogens and dengue disease is a global health threat. The geographic expansion of dengue viruses has led to co-circulation of all four dengue serotypes making it imperative that new DENV control strategies be devised.

OBJECTIVES Here we characterize dengue serotype-specific innate immune responses in Aedes aegypti and Aedes albopictus using DENV from Puerto Rico (PR).

METHODS Ae. aegypti and Ae. albopictus were infected with dengue serotype 1 and 2 isolated from Puerto Rico. DENV infected mosquito samples were collected and temporal change in expression of selected innate immune response pathway genes analyzed by quantitative real time PCR.

FINDINGS The Toll pathway is involved in anti-dengue response in Ae. aegypti, and Ae. albopictus. Infections with PR DENV-1 elicited a stronger response from genes of the Toll immune pathway than PR DENV-2 in Ae. aegypti but in infected Ae. albopictus expression of Toll pathway genes tended to be similar between the serotypes. Two genes (a ribosomal S5 protein gene and a nimrod-like gene) from Ae. albopictus were expressed in response to DENV.

MAIN CONCLUSIONS These studies revealed a role for antiviral genes in DENV serotype-specific interactions with DENV vectors, demonstrated that infections with DENV-2 can modulate the Toll immune response pathway in Ae. aegypti and elucidated candidate molecules that might be used to interfere with serotype specific vector-virus interactions.

Financial support: Department of Agriculture and Consumer Services (DACS) 2010 (grant 00090369 to BWA and CTS), and partially by the National Institutes of Health Southeast Regional Center of Excellence for Emerging Infections & Biodefense (grant 5-U54-AI-057157-09 / UNC SERCEB) subcontract to CTS.
+ Corresponding author:
Received 9 May 2017
Accepted 21 June 2017

Our Location

Memórias do Instituto Oswaldo Cruz

Av. Brasil 4365, Castelo Mourisco 
sala 201, Manguinhos, 21040-900 
Rio de Janeiro, RJ, Brazil

Tel.: +55-21-2562-1222

This email address is being protected from spambots. You need JavaScript enabled to view it.

Support Program


fiocruz governo
faperj cnpq capes